NCT06687967: A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 1)

Sponsor: Sanofi. Phase: PHASE3. Conditions: Lichen Simplex Chronicus